Mother (person) – Talk Bio

Actionable Insights Powered by AI

Rallybio Halts Development of Lead FNAIT Program Following Phase 2 Failure

2 weeks ago talkbio0Tagged Alloimmune thrombocytopenia, Biotech pipeline shift, Fetal and neonatal alloimmune thrombocytopenia, Fetus, immune disorder therapy, Infant, Newborn, Mother (person), Phase 2 clinical trial, Rallybio RLYB212

Rallybio RLYB212, Fetal and neonatal alloimmune thrombocytopenia (FNAIT), Phase 2 clinical trial, Maternal immune disorder therapy, Biotech pipeline shift

Revitalizing Maternal Health: Nonprofit Leverages Low-Dose Aspirin to Combat Preeclampsia Disparities

3 months ago talkbio0Tagged aspirin, Black Populations, GTPase-Activating Proteins, health disparity, Health Equity, Low-Dose, Mother (person), Pre-Eclampsia, SPIRIN

Preeclampsia, Maternal Health Equity, Low-Dose Aspirin, GAP—SPIRIN, Health Disparities, Black Maternal Health